Market Overview

UPDATE: Goldman Sachs Raises PT on Stryker Corporation on Completed Acquisition, Updated Model

Share:
Related SYK
Benzinga's Top Upgrades, Downgrades For November 16, 2017
Earnings Scheduled For October 26, 2017

In a report published Monday, Goldman Sachs reiterated its Buy rating on Stryker Corporation (NYSE: SYK), and slightly raised its price target from $71.00 to $72.00.

Goldman Sachs noted, “We update our model for the completed acquisition of Trauson Holdings and the announced $250mn ASR. Trauson is an orthopaedic device manufacturer headquartered in China with a primary focus on trauma and spine (77% of sales combined). 2012 revenue was around $75-80 million, growing at 25-30%. Stryker management indicated the transaction to be neutral to 2013E EPS and accretive thereafter. We believe there could be further upside to estimates should Stryker prove successful at leveraging Trauson's existing channels in China to sell a broader product suite.”

Stryker Corporation closed on Friday at $64.90.

Latest Ratings for SYK

DateFirmActionFromTo
Nov 2017BairdUpgradesNeutralOutperform
Oct 2017Canaccord GenuityMaintainsBuy
Oct 2017BarclaysMaintainsUnderweight

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings

 

Related Articles (SYK)

View Comments and Join the Discussion!

Partner Center